These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11466388)

  • 1. Evidence of IL-18 as a novel angiogenic mediator.
    Park CC; Morel JC; Amin MA; Connors MA; Harlow LA; Koch AE
    J Immunol; 2001 Aug; 167(3):1644-53. PubMed ID: 11466388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 contributes to angiogenesis in rheumatoid arthritis.
    Pickens SR; Volin MV; Mandelin AM; Kolls JK; Pope RM; Shahrara S
    J Immunol; 2010 Mar; 184(6):3233-41. PubMed ID: 20173024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.
    Volin MV; Woods JM; Amin MA; Connors MA; Harlow LA; Koch AE
    Am J Pathol; 2001 Oct; 159(4):1521-30. PubMed ID: 11583978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis.
    Pablos JL; Santiago B; Galindo M; Torres C; Brehmer MT; Blanco FJ; García-Lázaro FJ
    J Immunol; 2003 Feb; 170(4):2147-52. PubMed ID: 12574387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
    Volin MV; Koch AE
    J Interferon Cytokine Res; 2011 Oct; 31(10):745-51. PubMed ID: 21864160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.
    Salcedo R; Young HA; Ponce ML; Ward JM; Kleinman HK; Murphy WJ; Oppenheim JJ
    J Immunol; 2001 Jun; 166(12):7571-8. PubMed ID: 11390513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins.
    Nakao S; Kuwano T; Ishibashi T; Kuwano M; Ono M
    J Immunol; 2003 Jun; 170(11):5704-11. PubMed ID: 12759453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
    J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.
    Koch AE; Volin MV; Woods JM; Kunkel SL; Connors MA; Harlow LA; Woodruff DC; Burdick MD; Strieter RM
    Arthritis Rheum; 2001 Jan; 44(1):31-40. PubMed ID: 11212173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of endothelial cell activity by inhibition of TNFα.
    Shu Q; Amin MA; Ruth JH; Campbell PL; Koch AE
    Arthritis Res Ther; 2012 Apr; 14(2):R88. PubMed ID: 22534470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Junctional adhesion molecule-C is a soluble mediator of angiogenesis.
    Rabquer BJ; Amin MA; Teegala N; Shaheen MK; Tsou PS; Ruth JH; Lesch CA; Imhof BA; Koch AE
    J Immunol; 2010 Aug; 185(3):1777-85. PubMed ID: 20592283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
    Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
    J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium.
    Woods JM; Katschke KJ; Tokuhira M; Kurata H; Arai KI; Campbell PL; Koch AE
    J Immunol; 2000 Sep; 165(5):2755-63. PubMed ID: 10946307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
    Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
    Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
    Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
    J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis.
    Pickens SR; Chamberlain ND; Volin MV; Pope RM; Talarico NE; Mandelin AM; Shahrara S
    Arthritis Rheum; 2012 Aug; 64(8):2471-81. PubMed ID: 22392503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
    Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
    Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
    J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis.
    Lupia E; Montrucchio G; Battaglia E; Modena V; Camussi G
    Eur J Immunol; 1996 Aug; 26(8):1690-4. PubMed ID: 8765007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.
    Koch AE; Kunkel SL; Harlow LA; Mazarakis DD; Haines GK; Burdick MD; Pope RM; Walz A; Strieter RM
    J Clin Invest; 1994 Sep; 94(3):1012-8. PubMed ID: 8083342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.